Late-Onset Bone Metastasis 46 Years After Initial Surgery for Pheochromocytoma: A Case Report

Q4 Medicine
Fumio Ishizaki, Kaede Hiruma, Yusuke Tani, Hideaki Sugino, Tatsuro Sanami, Tsutomu Anraku, Masahiro Ikeda, Masayuki Tasaki, Kazuhide Saito, Yoshihiko Tomita
{"title":"Late-Onset Bone Metastasis 46 Years After Initial Surgery for Pheochromocytoma: A Case Report","authors":"Fumio Ishizaki,&nbsp;Kaede Hiruma,&nbsp;Yusuke Tani,&nbsp;Hideaki Sugino,&nbsp;Tatsuro Sanami,&nbsp;Tsutomu Anraku,&nbsp;Masahiro Ikeda,&nbsp;Masayuki Tasaki,&nbsp;Kazuhide Saito,&nbsp;Yoshihiko Tomita","doi":"10.1002/iju5.70086","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Pheochromocytoma is a rare catecholamine-producing tumor with metastatic potential. Recurrence after more than 40 years is exceptionally rare.</p>\n </section>\n \n <section>\n \n <h3> Case Presentation</h3>\n \n <p>During evaluation for ischemic colitis, a 71-year-old woman was found to have multiple bone metastases, possibly linked to catecholamine excess. She had undergone left adrenalectomy for pheochromocytoma at age 25. Bone biopsy confirmed metastatic pheochromocytoma, and immunohistochemical findings were similar to the original tumor. Urinary metanephrine and normetanephrine were markedly elevated. She declined systemic therapy and has remained clinically stable for 6 years, with her blood pressure well controlled on doxazosin.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>This case illustrates a recurrence 46 years after adrenalectomy, potentially representing the longest reported interval to date. It highlights the silent and indolent nature of some metastatic pheochromocytomas and underscores the necessity of lifelong follow-up. The patient's stable course also emphasizes the clinical heterogeneity of metastatic pheochromocytoma and supports the need for individualized follow-up and treatment strategies.</p>\n </section>\n </div>","PeriodicalId":52909,"journal":{"name":"IJU Case Reports","volume":"8 5","pages":"533-538"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iju5.70086","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IJU Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/iju5.70086","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction

Pheochromocytoma is a rare catecholamine-producing tumor with metastatic potential. Recurrence after more than 40 years is exceptionally rare.

Case Presentation

During evaluation for ischemic colitis, a 71-year-old woman was found to have multiple bone metastases, possibly linked to catecholamine excess. She had undergone left adrenalectomy for pheochromocytoma at age 25. Bone biopsy confirmed metastatic pheochromocytoma, and immunohistochemical findings were similar to the original tumor. Urinary metanephrine and normetanephrine were markedly elevated. She declined systemic therapy and has remained clinically stable for 6 years, with her blood pressure well controlled on doxazosin.

Conclusion

This case illustrates a recurrence 46 years after adrenalectomy, potentially representing the longest reported interval to date. It highlights the silent and indolent nature of some metastatic pheochromocytomas and underscores the necessity of lifelong follow-up. The patient's stable course also emphasizes the clinical heterogeneity of metastatic pheochromocytoma and supports the need for individualized follow-up and treatment strategies.

Abstract Image

嗜铬细胞瘤术后46年迟发性骨转移一例报告
嗜铬细胞瘤是一种罕见的具有转移潜力的产生儿茶酚胺的肿瘤。40年以上复发极为罕见。在评估缺血性结肠炎时,一名71岁妇女被发现多发性骨转移,可能与儿茶酚胺过量有关。她在25岁时因嗜铬细胞瘤接受了左肾上腺切除术。骨活检证实转移性嗜铬细胞瘤,免疫组化结果与原肿瘤相似。尿中肾上腺素和去甲肾上腺素明显升高。患者谢绝全身治疗,临床稳定6年,服用多沙唑嗪血压控制良好。结论:本病例显示肾上腺切除术后46年复发,可能是迄今为止报道的最长的复发间隔。它强调了一些转移性嗜铬细胞瘤的沉默和惰性性质,并强调了终身随访的必要性。患者的稳定病程也强调了转移性嗜铬细胞瘤的临床异质性,并支持个体化随访和治疗策略的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
IJU Case Reports
IJU Case Reports Medicine-Urology
CiteScore
0.60
自引率
0.00%
发文量
147
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信